Home › Stocks › BOLT › Changes
Who bought & sold BOLT (Q2 2026)
Funds holding (Q2 2026)24
New positions3
Added5
Reduced4
Exited3
As of Q2 2026, 24 institutional funds reported holding BOLT (Bolt Biotherapeutics): 3 opened new positions, 5 added, 4 trimmed and 3 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.
New positions (3)
| Fund | Shares | Value | Weight |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC New | 19.12K | $73.62K | — |
| NewEdge Advisors, LLC New | 2.53K | $9.74K | — |
| Citigroup Inc New | 41 | $158 | — |
Added to positions (5)
| Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|
| Citadel Advisors | 56.90K | $219.08K | — | +46.79K sh (+462.9%) |
| Renaissance Technologies | 98.62K | $379.71K | 0.0 | +21.40K sh (+27.7%) |
| Tower Research Capital LLC (TRC) | 1.71K | $6.58K | — | +617 sh (+56.5%) |
| Shay Capital LLC | 15.44K | $59.44K | 0.0 | +533 sh (+3.6%) |
| SBI Securities Co., Ltd. | 130 | $501 | — | +120 sh (+1200.0%) |
Reduced positions (4)
| Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|
| Nan Fung Group Holdings Ltd | 5.00K | $19.25K | 0.0 | -24.25K sh (-82.9%) |
| Geode Capital Management | 19.12K | $73.62K | — | -9.67K sh (-33.6%) |
| UBS Group AG | 255 | $982 | — | -532 sh (-67.6%) |
| Morgan Stanley | 3.15K | $12.11K | — | -44 sh (-1.4%) |
Exited positions (3)
Held in the prior quarter but not reported in the latest filing.
| Fund | Shares | Value | Weight |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC Exited | 42.58K | $172.03K | 0.1 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Exited | 11.66K | $47.09K | — |
| Vanguard Global Advisers, LLC Exited | 24 | $97 | — |